title: RAGE gene polymorphisms in patients with multiple sclerosis.
abstract: The pathogenesis of multiple sclerosis (MS), a devastating neuroinflammatory disorder of the central nervous system, has been presumed to involve the possible importance of the receptor for advanced glycation end products (RAGE). The aim of this study was to investigate the relevance of the genetic polymorphisms of RAGE in MS patients. A total of 168 patients with MS were enrolled; 136 healthy blood donors served as controls. The -374 T/ A, -479 T/C, and the G82S polymorphisms of RAGE were determined by restriction fragment length polymorphism (RFLP). There was a significant difference in RAGE -374 T/A genotype distribution between the controls and the MS patients. The AA homozygote variants were detected in 8% of the patients with MS, as compared with 19% of healthy controls (OR=2.75; 95% CI=1.319-5.733, p = 0.007). No differences were observed between the MS patients and the controls, concerning the frequencies of the -479 T/C and G82S genotypes of the RAGE. Our results revealed an association between the -374 T/A polymorphism of the RAGE promoter and MS. The genetic variant -374 AA (which has previously been shown to exert significant effects on transcriptional activity) can be considered a preventive factor as regards the occurrence of MS. Our findings support the view that RAGE plays a role in the development of MS.
authors.affiliation: Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Tiszlavicz
authors.forename: Zsofia
authors.initials: Z
authors.lastname: Gyulai
authors.forename: Krisztina
authors.initials: K
authors.lastname: Bencsik
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szolnoki
authors.forename: Agnes Katalin
authors.initials: AK
authors.lastname: Kocsis
authors.forename: Ferenc
authors.initials: F
authors.lastname: Somogyvári
authors.forename: László
authors.initials: L
authors.lastname: Vécsei
authors.forename: Yvette
authors.initials: Y
authors.lastname: Mándi
mesh_terms: D000328:Adult; D002490:Central Nervous System / Q000378:metabolism / Q000503:physiopathology; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D014644:Genetic Variation / Q000235:genetics; D005838:Genotype; D006720:Homozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009414:Nerve Growth Factors / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics*; D011485:Protein Binding / Q000235:genetics; D000067759:Receptor for Advanced Glycation End Products / Q000235:genetics*; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000235:genetics
chemical_list: D005819:Genetic Markers; D009414:Nerve Growth Factors; D000067759:Receptor for Advanced Glycation End Products; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins